No abstract
Introduction: Cannabis sativa has several therapeutic properties and has been used for millennials for healing purposes. Among its benefits are analgesic, antiemetic and tranquilizing effects, acting strongly on the nervous system. Objective: This study aims to emphasize the importance of Cannabidiol as a therapeutic purpose for epilepsy, especially in Brazil, where its use is still controlled. Method: A systematic literature review, using bibliographic searches carried out in the electronic databases LILACS, PubMed and SciELO with the descriptors “cannabidiol” and “epilepsy”. Of 1645 searches found, 06 were used in the study. Results: Epileptic seizures can be generalized or partial and are determined by the affected area. The treatment for epilepsy are drugs that decrease the arousal capacity of neural tissue and a significant percentage of individuals cannot control them with traditional drugs alone. Endocannabinoids work in response to epileptiform activity, to activate CB1 receptors for excitatory neurons, to contain excess neuronal activity, which occurs during seizures. It is proven that patients who use it do not have toxic adverse effects. Conclusions: In Brazil, Cannabis is a controlled drug and the fact that it is imported, interfere in the treatment, who is interrupted while patient waits the new dosage. The importance of cannabidiol as a target for research and studies is verified, as it has ample potential in the treatment of epilepsy and reduces brain damage caused by it. In order that patients with epilepsy, have improvements in their quality of life.
Introduction: Since the beginning of the pandemic in December 2019, COVID-19 caused by the infection of the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), in addition to the clinical manifestations already, can develop changes in the rate of blood clotting, where there are already notifications of Cerebrovascular Accident (CVA) associated with the virus. Objective: To know the characteristics of patients with COVID-19 affected by CVA, documented in the scientific literature. Method: A systematic literature review was carried out, using the MeSH Brower platform descriptors, namely: Stroke and Coronavirus, with an AND expression. The articles were searched in scientific databases: PubMed, MEDLINE Complete and SCIELO. 217 studies were found, of which 04 publications were included in this research. Results: Parallel studies on patient characteristics: elderly, male and comorbidities, such as hypertension, diabetes, heart disease and obesity, all risk factors for stroke. However, there were cases of young patients affected by CVA after the diagnosis of COVID-19. With regard to neurological changes, the researched articles state that most patients have symptoms such as deviation of the labial commissure on the right, dysarthria, aphasia, hemiplegia and hemianesthesia on the left. Conclusion: Although this incidence is not known, CVA is emerging as a complication of the COVID-19 pandemic. In this sense, further studies on the subject are necessary, since the elucidation of thrombotic mechanisms in patients with COVID- 19 can generate complications to prevent complications such as Cerebrovascular Accident.
Background: Greek, the word sklerosis means hardening. In medicine, the term sclerosis refers to the stiffening of body tissues - scars. These scars (sclerosis), when located in motor neurons, are signs of Amyotrophic Lateral Sclerosis (ALS), a neurodegenerative disease that affects neurons located in the primary motor cortex, brain stem, spinal cord and pyramidal tract. ALS has no cure and its treatment options are currently limited. Objectives: Review on the major complications of ALS, as well as the therapeutic methods for its treatment. Methods: Study conducted trough articles found on The New English Journal of Medicine, SpringerLink and Scholar Google and dated between 2009 and 2021. Results: ALS is known for the gradual atrophy of the muscle fibers associated with muscle loss, dysarthria and dysphagia complicated by sialorrhea, depending on the condition. All forms of the disease lead to paralysis, which causes the main consequent complication for the early mortality of patients - respiratory failure. The treatment of ALS has only one specific approved drug: riluzole, which decreases motor neuron damage, reducing disease progression and increasing patient survival. New therapeutic methods are being studied, such as treatment with stem cells and STING- induced inflammation, but they remain with limited evidence. Conclusions: ALS still has extremely restricted targeted treatment. There’s evident need for further studies aimed at a greater understanding of therapies with the potential to become effective in delaying the progression of the disease.
Este artigo debate o problema da inclusão escolar de crianças com transtorno do espectro autista (TEA). Para estabelecer o debate, foi feito um levantamento bibliográfico e referencial para uma revisão sistemática do tema. O objetivo é clarificar os conceitos de inclusão escolar e TEA para debater como é feito o processo educacional de crianças com TEA. Sendo assim, a partir da pesquisa científica de descritores como “inclusão escolar”, “transtorno do espectro autista”, foi observado, pelos diversos autores trabalhados, que ainda há muito o que se debater e trabalhar para que ocorra a inclusão escolar de crianças com TEA. Apesar das muitas tentativas, erros e acertos, o tema ainda é pouco trabalhado e divulgado, visto que há poucos profissionais capacitados na área.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.